• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic value of serum high-density lipoprotein cholesterol elevation in nonsmall cell lung cancer patients receiving radical surgery.

作者信息

Luo Fan, Zeng Kang-Mei, Zhang Zhong-Han, Zhou Ting, Zhan Jian-Hua, Lu Fei-Teng, Yang Yun-Peng, Huang Yan, Zhang Li, Zhao Hong-Yun

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.

出版信息

Clin Transl Med. 2020 Jun;10(2):e94. doi: 10.1002/ctm2.94. Epub 2020 Jun 5.

DOI:10.1002/ctm2.94
PMID:32508010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403695/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/7403695/e6892bd6d62e/CTM2-10-e94-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/7403695/244daeda3c74/CTM2-10-e94-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/7403695/e6892bd6d62e/CTM2-10-e94-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/7403695/244daeda3c74/CTM2-10-e94-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/7403695/e6892bd6d62e/CTM2-10-e94-g002.jpg

相似文献

1
Prognostic value of serum high-density lipoprotein cholesterol elevation in nonsmall cell lung cancer patients receiving radical surgery.血清高密度脂蛋白胆固醇升高在接受根治性手术的非小细胞肺癌患者中的预后价值。
Clin Transl Med. 2020 Jun;10(2):e94. doi: 10.1002/ctm2.94. Epub 2020 Jun 5.
2
Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction.非高密度脂蛋白胆固醇可预测ST段抬高型心肌梗死患者的非致死性复发性心肌梗死。
Lipids Health Dis. 2017 Jan 23;16(1):20. doi: 10.1186/s12944-017-0418-5.
3
Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.晚期非小细胞肺癌患者治疗前血清HER-2/neu癌蛋白水平作为预后和预测因素的研究。
Cancer. 2001 Oct 1;92(7):1896-904.
4
Preoperative serum lipids as prognostic predictors in esophageal squamous cell carcinoma patients with esophagectomy.术前血脂作为接受食管切除术的食管鳞状细胞癌患者的预后预测指标
Oncotarget. 2017 Jun 20;8(25):41605-41619. doi: 10.18632/oncotarget.15651.
5
Evaluation of Prognostic Nutritional Index in Patients Undergoing Radical Surgery with Nonsmall Cell Lung Cancer.非小细胞肺癌根治性手术患者预后营养指数的评估
Nutr Cancer. 2015;67(5):741-7. doi: 10.1080/01635581.2015.1032430. Epub 2015 May 5.
6
Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects.癌症患者的血清脂蛋白谱。与非癌症受试者的比较。
Int J Clin Lab Res. 2000;30(3):141-5. doi: 10.1007/s005990070013.
7
Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer.血清高密度脂蛋白胆固醇在胆囊癌患者中的预后价值。
Rev Esp Enferm Dig. 2019 Nov;111(11):839-845. doi: 10.17235/reed.2019.6201/2019.
8
Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis.血清总胆固醇和高密度脂蛋白胆固醇在癌症幸存者中的预后作用：系统评价和荟萃分析。
Clin Chim Acta. 2018 Feb;477:94-104. doi: 10.1016/j.cca.2017.11.039. Epub 2017 Dec 6.
9
Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).血清低密度脂蛋白及诊断时的低密度脂蛋白表达水平是小细胞肺癌（SCLC）患者的良好预后因素。
BMC Cancer. 2017 Apr 14;17(1):269. doi: 10.1186/s12885-017-3239-z.
10
Tracking of serum cholesterol and lipoprotein levels from the first year of life.从生命的第一年开始追踪血清胆固醇和脂蛋白水平。
Pediatrics. 1993 May;91(5):949-54.

引用本文的文献

1
Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel-based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer.肿瘤退缩率、程序性死亡受体配体1（PD-L1）表达、基于帕博利珠单抗/白蛋白结合型紫杉醇的治疗方案、鳞状细胞癌和合并症与非小细胞肺癌新辅助化疗免疫治疗的疗效独立相关。
Front Oncol. 2023 Jan 27;12:1057646. doi: 10.3389/fonc.2022.1057646. eCollection 2022.

本文引用的文献

1
Outcomes of Patients with Clinical Stage I-IIIA Large-Cell Neuroendocrine Lung Cancer Treated with Resection.接受手术治疗的临床I-IIIA期大细胞神经内分泌肺癌患者的治疗结果
J Clin Med. 2020 May 7;9(5):1370. doi: 10.3390/jcm9051370.
2
A molecular and staging model predicts survival in patients with resected non-small cell lung cancer.一种分子和分期模型预测了可切除非小细胞肺癌患者的生存情况。
BMC Cancer. 2018 Oct 11;18(1):966. doi: 10.1186/s12885-018-4881-9.
3
AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients.
极光激酶A（AURKA）、Dlg 家族成员5（DLGAP5）、肿瘤蛋白X（TPX2）、驱动蛋白家族成员11（KIF11）和细胞骨架相关蛋白5（CKAP5）：五个特定的有丝分裂相关基因与非小细胞肺癌患者的不良预后相关。
Int J Oncol. 2017 Feb;50(2):365-372. doi: 10.3892/ijo.2017.3834. Epub 2017 Jan 2.
4
A Threshold of Systemic MAGE-A Gene Expression Predicting Survival in Resected Non-Small Cell Lung Cancer.系统 MAGE-A 基因表达阈值预测非小细胞肺癌切除术后的生存。
Clin Cancer Res. 2017 Mar 1;23(5):1213-1219. doi: 10.1158/1078-0432.CCR-16-0557. Epub 2016 Aug 19.
5
Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.非小细胞肺癌的基因分型和基因组分析：对当前和未来治疗的影响。
J Clin Oncol. 2013 Mar 10;31(8):1039-49. doi: 10.1200/JCO.2012.45.3753. Epub 2013 Feb 11.
6
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies.一种实用的分子检测方法，可预测非小细胞肺癌（非鳞癌）切除术后的生存情况：开发和国际验证研究。
Lancet. 2012 Mar 3;379(9818):823-32. doi: 10.1016/S0140-6736(11)61941-7. Epub 2012 Jan 27.
7
Survival after surgery in stage IA and IB non-small cell lung cancer.IA期和IB期非小细胞肺癌手术后的生存率。
Am J Respir Crit Care Med. 2008 Mar 1;177(5):516-23. doi: 10.1164/rccm.200706-815OC. Epub 2007 Nov 15.
8
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.IIIA-N2期非小细胞肺癌诱导化疗后手术切除与放射治疗的随机对照试验
J Natl Cancer Inst. 2007 Mar 21;99(6):442-50. doi: 10.1093/jnci/djk093.
9
Changes in serum lipids and lipoproteins in cancer patients during chemotherapy.癌症患者化疗期间血清脂质和脂蛋白的变化。
Cancer Chemother Pharmacol. 1992;30(5):412-6. doi: 10.1007/BF00689971.